BlackRock Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

BlackRock Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.01M	Buy	108,364 +2,226	+2%	+$20K	﹤0.01%	1856
2016 Q3	$1.04M	Buy	106,138 +54,612	+106%	+$737K	﹤0.01%	1801
2016 Q2	$728K	Buy	51,526 +10,516	+26%	+$164K	﹤0.01%	1913
2016 Q1	$573K	Buy	41,010 +33,073	+417%	+$485K	﹤0.01%	2009
2015 Q4	$162K	Buy	7,937 +3,715	+88%	+$57.3K	﹤0.01%	2681
2015 Q3	$55K	Sell	4,222 -35	-0.8%	-$581	﹤0.01%	3296
2015 Q2	$65K	Buy	4,257 +1,496	+54%	+$28.7K	﹤0.01%	3284
2015 Q1	$55K	Buy	2,761 +527	+24%	+$11.8K	﹤0.01%	3221
2014 Q4	$47K	Hold	2,234	–	–	﹤0.01%	3287
2014 Q3	$42K	Buy	2,234 +167	+8%	+$3.02K	﹤0.01%	3313
2014 Q2	$48K	Buy	+2,067	New	+$36.4K	﹤0.01%	3264

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's AGTC Position: Q4 2016 in Review

BlackRock Advisors increased its Applied Genetic Technologies Corporation (AGTC) stake by 2.1% in Q4 2016, buying an estimated $20K and bringing the position to 108,364 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

BlackRock Advisors first reported a position in AGTC in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.04M in Q3 2016. 90 funds tracked by Wall St. Rank hold AGTC as of Q4 2016.

BlackRock Advisors held 108,364 shares of Applied Genetic Technologies Corporation worth $1.01M as of Q4 2016.
BlackRock Advisors bought 2,226 Applied Genetic Technologies Corporation shares in Q4 2016, an estimated $20K.
Applied Genetic Technologies Corporation made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1856 holding.
BlackRock Advisors first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and has held it in 11 quarters since.
BlackRock Advisors's Applied Genetic Technologies Corporation position peaked at $1.04M in Q3 2016.
90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.